![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 14/5406 | (2013.01) |
A61K 47/66 | (2017.01) | ||
A61K 47/42 | (2017.01) | ||
C07K 14/195 | (2013.01) | ||
A61K 47/68 | (2017.01) | ||
C07K 14/4747 | (2013.01) | ||
A61P 25/00 | (2006.01) | ||
C07K2319/55 | (2013.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 25/00 | (2018.01) | ||
C07K 14/195 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
C07K 14/47 | (2006.01) | ||
C07K2319/00 | (2013.01) | ||
C07K 14/54 | (2006.01) | ||
A61K 9/0012 | (2013.01) | ||
A61K 38/164 | (2013.01) | ||
C07K 14/76 | (2006.01) | ||
C07K 19/00 | (2006.01) |
(11) | Number of the document | 3694558 |
(13) | Kind of document | T |
(96) | European patent application number | 18865485.9 |
Date of filing the European patent application | 2018-10-10 | |
(97) | Date of publication of the European application | 2020-08-19 |
(45) | Date of publication and mention of the grant of the patent | 2024-04-10 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/IB2018/001284 |
Date | 2018-10-10 |
(87) | Number | WO 2019/073299 |
Date | 2019-04-18 |
(30) | Number | Date | Country code |
201762570578 P | 2017-10-10 | US |
(72) |
MERCHANT, Fahar , CA
|
(73) |
Medicenna Therapeutics Inc. ,
200-1920 Youge Street, Toronto, ON M4S 3E2,
CA
|
(54) | IL-4-FUSION FORMULATIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS |
IL-4-FUSION FORMULATIONS FOR TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) TUMORS |